AI assistant
Sending…
MANGOCEUTICALS, INC. — Director's Dealing 2025
Dec 9, 2025
34879_dirs_2025-12-09_a3548e16-c0d7-471b-8dd1-988f15232fa5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANGOCEUTICALS, INC. (MGRX)
CIK: 0001938046
Period of Report: 2025-12-05
Reporting Person: JOHNSTON EUGENE M (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-05 | Common Stock | S | 10000 | $1.128 | Disposed | 128333 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $1.10 to $1.20, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
More from MANGOCEUTICALS, INC.
Interim / Quarterly Report
2026
May 19
Annual Report
2026
Apr 1
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 19
Delisting Announcement
2026
Feb 6
Capital/Financing Update
2026
Jan 23
Capital/Financing Update
2026
Jan 13
Regulatory Filings
2025
Dec 19